Esperion Therapeutics, Inc.
ESPR
Revenue
87.31M
▲4.92M▲5.98%
3 Months ChangeAssets
364.02M
▲16.94M▲4.88%
3 Months ChangeLiabilities
815.38M
▲34.79M▲4.46%
3 Months ChangeFree Cash Flow
-22.63M
▼-76.38M▼-142.09%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 10-Q
ID: 0001628280-24-036762
2024-08-12
Form 8-K
ID: 0001628280-24-036597
2024-08-05
Form 8-K
ID: 0001628280-24-034766
2024-06-28
Form 8-K
ID: 0001628280-24-030403
2024-05-28
Form 8-K
ID: 0001628280-24-025418
2024-05-08
Form 8-K
ID: 0001628280-24-021717
2024-05-07
Form 10-Q
ID: 0001628280-24-020862
2024-05-07
Form 8-K
ID: 0001628280-24-020841
2024-02-27
Form 8-K
ID: 0001628280-24-007035
2024-01-22
Form 8-K
ID: 0001104659-24-005351